Compare
Ascend Wellness Holdings, Inc. vs Cresco Labs Inc. vs USANA Health Sciences Inc vs Jushi Holdings Inc.
| Latest fiscal year | Ascend Wellness Holdings, Inc. AAWH | Cresco Labs Inc. CRLBF | USANA Health Sciences Inc USNA | Jushi Holdings Inc. JUSH |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-01-03 | 2025-12-31 |
| Revenue | $500.58M | $655.85M | $925.26M | $262.91M |
| Revenue growth (YoY) | -10.9% | -9.5% | +8.3% | +2.1% |
| Gross margin | 33.9% | 49.5% | 78.3% | 43.4% |
| Operating margin | -3.4% | -4.3% | 4.0% | 1.8% |
| Net margin | -23.6% | -20.6% | 1.2% | -26.1% |
| Net income | -$118.19M | -$135.41M | $10.76M | -$68.59M |
| EPS (Diluted) | -$0.58 | -$0.38 | $0.58 | -$0.35 |
| Operating cash flow | $38.05M | $72.89M | $22.35M | $17.73M |
| Free cash flow | $12.04M | $37.75M | $8.53M | $1.64M |
| Cash & equivalents | $85.68M | $57.90M | $158.38M | $24.05M |
| Total assets | $907.93M | $1.20B | $742.91M | $422.34M |
| Total liabilities | $954.55M | $944.80M | $156.64M | $537.69M |
| Shareholders' equity | -$46.62M | $340.45M | $533.10M | -$115.34M |
| Return on year-end equity | n/a | -39.8% | 2.0% | n/a |
| Shares outstanding | 202.22M | n/a | 18.28M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Ascend Wellness Holdings, Inc. | Cresco Labs Inc. | USANA Health Sciences Inc | Jushi Holdings Inc. |
|---|---|---|---|---|
| Latest | $500.58M Ended 2025-12-31 | $655.85M Ended 2025-12-31 | $925.26M Ended 2026-01-03 | $262.91M Ended 2025-12-31 |
| 1 year earlier | $561.60M Ended 2024-12-31 | $724.34M Ended 2024-12-31 | $854.50M Ended 2024-12-28 | $257.52M Ended 2024-12-31 |
| 2 years earlier | $518.59M Ended 2023-12-31 | $770.88M Ended 2023-12-31 | $921.01M Ended 2023-12-30 | $269.44M Ended 2023-12-31 |
| 3 years earlier | $405.93M Ended 2022-12-31 | n/a | $998.60M Ended 2022-12-31 | $284.28M Ended 2022-12-31 |
| 4 years earlier | $332.38M Ended 2021-12-31 | n/a | $1.19B Ended 2022-01-01 | $209.29M Ended 2021-12-31 |